ACRV Earnings

Quarterly EPS
$-0.59
Q3 2024
$-0.60
Q4 2024
$-0.51
Q1 2025
$-0.55
Q2 2025
$-0.47
Q3 2025
$-0.49
Q4 2025
$-0.49
Q1 2026
$-0.43
Q2 2026
Latest RevenueN/A
Latest Net Income-17964000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.430-17964000—+21.8%
Q1 2026-$0.490-19042000—+3.9%
Q4 2025-$0.490-18985000—+18.3%
Q3 2025-$0.470-18234000—+20.3%
Q2 2025-$0.550-21006000—-5.8%
Q1 2025-$0.510-19680000—+30.1%
Q4 2024-$0.600-22831000—+30.2%
Q3 2024-$0.590-22441000—+10.6%
Q2 2024-$0.520-18798000——
Q1 2024-$0.730-16486000——
Q4 2023-$0.860-19252000——
Q3 2023-$0.660-14466000——
Acrivon Therapeutics (ACRV) — Earnings